American Journal of Ophthalmology
Volume 150, Issue 5 , Pages 656-665.e1 , November 2010

Contact Lens–Induced Subconjunctival Hemorrhage

  • Tatsuya Mimura

      Affiliations

    • Department of Ophthalmology, Toranomon Hospital, Tokyo, Japan
    • Okinaka Memorial Institute for Medical Research, Tokyo, Japan
    • Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    • Corresponding Author InformationInquiries to Tatsuya Mimura, Department of Ophthalmology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan
    • ,
  • Satoru Yamagami

      Affiliations

    • Department of Ophthalmology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
    • ,
  • Mikiro Mori

      Affiliations

    • Department of Ophthalmology, Toranomon Hospital, Tokyo, Japan
    • Okinaka Memorial Institute for Medical Research, Tokyo, Japan
    • ,
  • Hideharu Funatsu

      Affiliations

    • Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, Chiba, Japan
    • ,
  • Tomohiko Usui

      Affiliations

    • Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    • ,
  • Hidetaka Noma

      Affiliations

    • Department of Ophthalmology, Yachiyo Medical Center, Tokyo Women's Medical University, Chiba, Japan
    • ,
  • Shiro Amano

      Affiliations

    • Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan

,Accepted 25 May 2010.

References 

  1. Fukuyama J, Hayasaka S, Yamada K, Setogawa T. Causes of subconjunctival hemorrhage. Ophthalmologica. 1990;200(2):63–67
  2. Pitts JF, Jardine AG, Murray SB, Barker NH. Spontaneous subconjunctival haemorrhage—a sign of hypertension?. Br J Ophthalmol. 1992;76(5):297–299
  3. Wilson RJ. Subconjunctival hemorrhage: overview and management. J Am Optom Assoc. 1986;57(5):376–380
  4. Mimura T, Usui T, Yamagami S, et al. Recent causes of subconjunctival hemorrhage. Ophthalmologica. 2009;224(3):133–137
  5. Mimura T, Yamagami S, Funatsu H, et al. Management of subconjunctival haematoma by tissue plasminogen activator. Clin Experiment Ophthalmol. 2005;33(5):541–542
  6. Superstein R, Gomolin JE, Hammouda W, Rosenberg A, Overbury O, Arsenault C. Prevalence of ocular hemorrhage in patients receiving warfarin therapy. Can J Ophthalmol. 2000;35(7):385–389
  7. Bodack MI. A warfarin-induced subconjunctival hemorrhage. Optometry. 2007;78(3):113–118
  8. Mimura T, Usui T, Yamagami S, et al. Subconjunctival hemorrhage and conjunctivochalasis. Ophthalmology. 2009;116(10):1880–1886
  9. Mimura T, Usui T, Yamamoto H, et al. Conjunctivochalasis and contact lenses. Am J Ophthalmol. 2009;148(1):20–25
  10. Holden BA. The Glenn A (Fry Award lecture 1988: the ocular response to contact lens wear). Optom Vis Sci. 1989;66(11):717–733
  11. Mimura T, Yamagami S, Usui T, et al. Location and extent of subconjunctival hemorrhage. Ophthalmologica. 2009;224(2):90–95
  12. Höh H, Schirra F, Kienecker C, Ruprecht KW. Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye. Ophthalmologe. 1995;92(6):802–808
  13. Meller D, Tseng SC. Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol. 1998;43(3):225–232
  14. Mimura T, Yamagami S, Usui T, et al. Changes of conjunctivochalasis with age in a hospital-based study. Am J Ophthalmol. 2009;147(1):171–177
  15. Li DQ, Meller D, Liu Y, Tseng SC. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci. 2000;41(2):404–410
  16. Meller D, Li DQ, Tseng SC. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha. Invest Ophthalmol Vis Sci. 2000;41(10):2922–2929
  17. Di Pascuale MA, Espana EM, Kawakita T, Tseng SC. Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br J Ophthalmol. 2004;88(3):388–392
  18. Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328(8):584
  19. Tsubota K, Nakamori K. Effects of ocular surface area and blink rate on tear dynamics. Arch Ophthalmol. 1995;113(2):155–158
  20. Watanabe A, Yokoi N, Kinoshita S, Hino Y, Tsuchihashi Y. Clinicopathologic study of conjunctivochalasis. Cornea. 2004;23(3):294–298
  21. Yokoi N, Komuro A, Nishii M, et al. Clinical impact of conjunctivochalasis on the ocular surface. Cornea. 2005;24(8 Suppl):S24–S31
  22. Uchino M, Dogru M, Yagi Y, et al. The features of dry eye disease in a Japanese elderly population. Optom Vis Sci. 2006;83(11):797–802
  23. Erdogan-Poyraz C, Mocan MC, Irkec M, Orhan M. Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion. Cornea. 2007;26(3):290–293
  24. Wang Y, Dogru M, Matsumoto Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol. 2007;144(6):930–937
  25. Yokoi N, Inatomi T, Kinoshita S. Surgery of the conjunctiva. Dev Ophthalmol. 2008;41:138–158
  26. Lemp MA. Contact lenses and associated anterior segment disorders: dry eye, blepharitis, and allergy. Ophthalmol Clin North Am. 2003;16(3):463–469
  27. Holden BA, Sweeney DF, Seger RG. Epithelial erosions caused by thin high water content lenses. Clin Exp Optom. 1986;69:103–107
  28. Guillon JP. Tear film structure on contact lenses. In:  Holly FJ editors. The preocular tear film in health, disease, and contact lens wear. Lubbock, Texas: Dry Eye Institute; 1986;p. 914–939
  29. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40(11):2506–2512
  30. Prabhasawat P, Tseng SC. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol. 1998;82(6):666–675
  31. Oguz H, Karadede S, Bitiren M, Gurler B, Cakmak M. Tear functions in patients with pinguecula. Acta Ophthalmol Scand. 2001;79(3):262–265
  32. Balogun MM, Ashaye AO, Ajayi BG, Osuntokun OO. Tear break-up time in eyes with pterygia and pingueculae in Ibadan. West Afr J Med. 2005;24(2):162–166
  33. Fotouhi A, Hashemi H, Khabazkhoob M, Mohammad K. Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study. Eye. 2009;23(5):1125–1129
  34. Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1998;26(Suppl 1):S2–S5
  35. Lim R, Mitchell P, Cumming RG. Cataract associations with pinguecula and pterygium: the Blue Mountains Eye Study. Am J Ophthalmol. 1998;126(5):717–719
  36. Pham TQ, Wang JJ, Rochtchina E, Mitchell P. Pterygium/pinguecula and the five-year incidence of age-related maculopathy. Am J Ophthalmol. 2005;139(3):536–537

PII: S0002-9394(10)00395-8

doi: 10.1016/j.ajo.2010.05.028

American Journal of Ophthalmology
Volume 150, Issue 5 , Pages 656-665.e1 , November 2010

Article Tools

* Image Usage & Resolution